Irrus Investments
Edit

Irrus Investments

https://www.irrusinvestments.com
Last activity: 22.05.2024
Active
Invests in categories: MedTechHealthTechTechnologyLifeHardwareProductCareBioTechDeliveryFinTech
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Portfolio
30
Persons
5
Mentions
5
Employees: 1-10

Portfolio 30

DateNameWebsiteTotal RaisedLocation
22.05.2024Axalbionaxalbion.com--
22.05.2024Soft X-Ray...siriusxt.com-Ireland, D...
23.07.2023Sigrid The...sigridthx.com$15.04MSweden, St...
23.07.2023DermViewallview.ie$2.1MIreland, L...
23.07.2023Gasgon Med...gasgonmedical.com$2.39MIreland, M...
23.07.2023SymPhysis ...symphysismedical.com$3.68MIreland, C...
23.07.2023Ovagenovagen.ie-Ireland, C...
23.07.2023Cinclus Ph...cincluspharma.com$26.47MSweden, St...
23.07.2023Byowavebyowave.com-Ireland
23.07.2023OncoAssure...oncoassure.com-Ireland, L...
Show more

Persons 5

DateFirst NameLast NameTitleLinkedInLocation
-MIKERYANDirectorlinkedin.c...-
-FRANKKEANEDirector-
-EMILYRYANDirectorlinkedin.c...-
-TONYTREACYDirectorlinkedin.c...-
-AIDANO’DRISCOLL...Directorlinkedin.c...-

Mentions in press and media 5

DateTitleDescription
31.03.2023Ireland’s Bluedrop Medical raises €10.5 million investment creating 25 new jobs this yearGalway-based med-tech Bluedrop Medical has raised €10.5 million in an oversubscribed funding round and says it will create 25 new jobs this year. The round was co-led by Atlantic Bridge and Elkstone, and includes the European Innovation Cou...
25.01.2023Dublin's Deciphex rakes in €3.9 million to bring AI to more pathology labsIrish digital pathology startup Deciphex extended its series B round to €14.4 million after raising €3.9 million led by Seroba Life Sciences and its existing investors. In conjunction with the extended series B round, Seroba partner Jennife...
19.05.2022Irish AI-driven pathology startup nabs $11.5 millionPathology is heading for a crunch point due to increasing volumes, increasing complexity and flat to declining pathologist numbers. Clinical pathologists are limited assets worldwide, and their number is predicted to significantly decrease ...
15.02.2017OncoMark Secures €2.1M in FundingPictured were Dawn Walsh, Kernel Capital; Des O’Leary, CEO, OncoMark; Professor William Gallagher, Director, UCD Conway Institute and co-founder, OncoMark; Deirdre Glenn, Manager, Lifesciences Sector, Enterprise Ireland and Kevin Healy, Sen...
-Irish AI-driven pathology startup nabs $11.5 millionPathology is heading for a crunch point due to increasing volumes, increasing complexity and flat to declining pathologist numbers. Clinical pathologists are limited assets worldwide, and their number is predicted to significantly decrease ...

Reviews 0

Sign up to leave a review

Sign up Log In